TSHA-117

N/A

Report date: 2024/11/20 15:58:44

Base Information

Drug NameTSHA-117
Drug Alias NameTSHA-117
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionForkhead box protein G1 gene transference
TargetsForkhead box protein G1
Therapy Area/IndicationsChild Development Disorders, Pervasive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity of Texas Southwestern Medical CenterTaysha Gene Therapies Inc
China Registration ClassN/A

Develop Information

Active CompaniesUniversity of Texas Southwestern Medical Center
Inactive CompaniesN/A
Active IndicationsChild Development Disorders, Pervasive
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A